Print

AcelRx Pharmaceuticals (ACRX) to Present at the Piper Jaffray 24th Annual Healthcare Conference  
11/21/2012 8:50:44 AM

REDWOOD CITY, Calif., Nov. 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Piper Jaffray 24th Annual Healthcare Conference at The New York Palace in New York, NY. The presentation is scheduled for Tuesday, November 27, 2012 at 11:00 a.m. ET/8:00 a.m. PT.

SOURCE AcelRx Pharmaceuticals, Inc.


//-->